Clinical trial
Single Center, Placebo Controlled, Double-Blind Study to the Treatment of HPV Infected Cervix With AV2 Antiviral Spray and Assessment of Viral Load
NCT01654822 is registered in ClinicalTrials.gov with Cesa Projects International as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single Center, Placebo Controlled, Double-Blind Study to the Treatment of HPV Infected Cervix With AV2 Antiviral Spray and Assessment of Viral Load
- Lead sponsor
- Cesa Projects International
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- August 31, 2012
- Completion date
- January 31, 2013
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
genital human papilloma virus infection